BioCentury | Nov 1, 2017
Translation in Brief

New Therapeutic Targets and Biomarkers: October 2017

...of Minnesota Distillery Therapeutics Renal cancer FOXO-induced long non-coding RNA 1 (FILNC1) Patient sample and cell culture studies suggest promoting FILNC1...
BioCentury | Oct 10, 2017
Distillery Therapeutics

Cancer

...FILNC1 were lower in tumors than in corresponding normal kidney tissue, and low expression of FILNC1...
...line with low FILNC1 expression and cultured under glucose starvation conditions, vector-mediated overexpression of a FILNC1...
...could include identifying and testing promoters of FILNC1 expression in animal models of ccRCC. TARGET/MARKER/PATHWAY: FOXO-induced long non-coding RNA 1 (FILNC1)...
Items per page:
1 - 2 of 2